Zimmer Biomet Holdings (ZBH) Liabilities and Shareholders Equity (2009 - 2026)

Zimmer Biomet Holdings has reported Liabilities and Shareholders Equity for 18 years, with the latest figure at $22.7 billion in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 2.42% year-over-year to $22.7 billion; the trailing twelve-month figure through Mar 2026 stood at $92.2 billion (up 6.2% YoY), and the FY2025 full-year result was $23.1 billion, up 8.08% from the prior year.
• Liabilities and Shareholders Equity for Q1 2026 stood at $22.7 billion, down from $23.1 billion in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $23.5 billion in Q3 2025, with the low at $21.1 billion in Q4 2022.
• Average Liabilities and Shareholders Equity over 5 years is $21.8 billion, with a median of $21.5 billion recorded in 2023.
• Year-over-year, Liabilities and Shareholders Equity decreased 11.44% in 2022 and advanced 8.14% in 2025.
• Tracing ZBH's Liabilities and Shareholders Equity over 5 years: stood at $21.1 billion in 2022, then rose by 2.05% to $21.5 billion in 2023, then slipped by 0.61% to $21.4 billion in 2024, then advanced by 8.08% to $23.1 billion in 2025, then dropped by 1.6% to $22.7 billion in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $22.7 billion (Q1 2026), $23.1 billion (Q4 2025), and $23.5 billion (Q3 2025), per Business Quant data.

Peer Comparison